Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Nothing in this 10Q that should have initiated the restriction

Milestone,

This makes a lot of sense to me.

Do you think that the business resolution method of settlement may be applied to other infringing companies such as the A's as a way to continue the licensing program now that TPL is trying to extract more $ from infringers?  That is to grant a license for the MMP with the terms set and collection after the patents pass or fail the USPTO re-examination or whatever factors are in the J's settlement.

All the best,

Steve

Share
New Message
Please login to post a reply